LFVN NASDAQ Week ended 31 Jul 2026

Weekly Investor Report

Lifevantage Corporation · Consumer Defensive · Packaged Foods

Open interactive chart View report data
Latest close 6.43 USD
-1.5% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 11.4% above the Trend Line and sits at 24.0% of its 52-week range. The latest completed week returned -1.5%, after a 3.4% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is volatility with 52/100 conviction, while the latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal; earnings are due in 33d.

Setup score 32 out of 100
Latest Close 6.43 USD 31 Jul 2026
1W Return -1.5% latest completed week
4W Return 3.4% short-term follow-through
12W Return 21.1% quarterly tape
Trend Breadth 15.4% 8 of 52 weeks active
Volume Ratio 0.2x vs 13-week average
What is working
  • The trend backdrop is active with a 8-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Activity pressure is positive on the latest completed week.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Price is below Fair Value, so the market is still discounting the latest tape.
  • The share remains more than 20% below its 52-week high.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.5% Latest completed week; four-week move 3.4%. Indicator stack 36/46 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 52/100 conviction; expected move 27.9%. News sentiment 50/100 55 relevant articles in the latest sentiment read. Event risk 33d Next report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 11.4% above the Trend Line and sits at 24.0% of its 52-week range. The latest completed week returned -1.5%, after a 3.4% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.2x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.5712-week average 0.40

12-week confirmation

Trend active8/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership1/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.57Current proprietary activity-pressure read.
Buy signals1Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers

No recent accumulation markers. No reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 3.4% over four weeks, 21.1% over 12 weeks, and -47.5% over one year. The current trend has remained active for 8 consecutive weeks.

Performance by holding period

1W-1.5%
4W3.4%
12W21.1%
26W23.2%
52W-47.5%
Active trend streak8 weeks
Active weeks in one year8
Trend breadth15.4%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure0.18Latest activity-pressure read.
Pressure change-84.5%Four-week change in activity pressure.
Leadership-17.86Latest relative-leadership reading.
RS change39.7%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength81/100Blend of value, momentum, and quality. Underlying universe rank 20; rank 1 is best.
Value84/100Relative valuation strength. Underlying universe rank 17; rank 1 is best.
Quality87/100Profitability and accounting quality. Underlying universe rank 14; rank 1 is best.
Momentum5/100Medium-term price momentum. Underlying universe rank 96; rank 1 is best.
Growth2/100Revenue and earnings growth. Underlying universe rank 99; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Value-quality framework72/100Value and quality alignment from the Sharemaestro SVQF framework.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
14.3x
Price divided by trailing earnings.
Price / sales
0.4x
Market value relative to trailing revenue.
EV / EBITDA
8.4x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
11.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
78.1%
Gross profit retained from each unit of revenue.
Operating margin
3.5%
Operating profit retained from revenue.
Free-cash-flow margin
4.7%
Free cash flow generated from revenue.
Return on invested capital
18.5%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-12.2%
Latest one-year revenue growth.
EPS growth
-37.1%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-37.9%
Latest one-year free-cash-flow growth.
Piotroski F-score
7/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
2.8%
Cash dividends relative to market value.
Buyback yield
7.3%
Net share repurchases relative to market value.
Shareholder yield
10.2%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.2x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

LFVN shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 27.9%, and Sharemaestro trend signal active.

Conviction52/100
Expected move27.9%
Put/call volume0.00
Pressure100
Speculation2
Volatility96
Trend agreement0
Open options detail
Insider activity1 / 4

1 acquisitions and 4 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment50/100

Weighted news tone is neutral across 55 relevant articles.

5 positive · 44 neutral · 6 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings33dNext report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
Options expected move27.9%Nearest-chain priced movement where available.
52-week drawdown-56.0%Distance below the 52-week high.
13-week volatility16.1%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher11 of 2614 weeks finished lower.
Best week+40.3%Week of 29 May.
Worst week-29.2%Week of 19 Jun.
Latest week-1.5%Week of 31 Jul.

Shape of recent returns

Strong gains9
Modest gains2
Flat weeks1
Modest losses7
Sharp losses7
Recent vol16.1%13-week weekly-return volatility.
Base vol9.7%52-week weekly-return volatility.
Up/down split16/35Count of positive and negative weeks in the 52-week window.
Average skew9.2% / -5.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape28/100

Trend, activity pressure, participation, and risk combine to a 28/100 tape read.

 Indicator analysis58/100

Latest 12-week confirmation: trend 8/12, activity pressure 12/12, relative leadership 1/12.

Activity pressure 0.57; No reversal markers Factors66/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Tiny Titans rank 68; Buyback Yield rank 8; Small Cap Core rank 16 SVQF72/100

Value and quality alignment from the Sharemaestro SVQF framework.

Composite rank 206.0 of 726 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options35/100

LFVN shows volatility options pressure with a 52/100 conviction score, put-call volume ratio of 0.00, expected move of 27.9%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 27.9% Sentiment50/100

Weighted news tone is neutral across 55 relevant articles.

LFVN|LifeVantage Corp|Price:6.340|Chg%:-0.090 Insiders1 / 4

1 acquisitions and 4 disposals in the latest 180-day insider tape.

 Earnings33d

Next report is scheduled for 03 Sep 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20266.43 USD-1.5%5.77 USD9.02 USD0.18-17.86329.5KOn
24 Jul 20266.53 USD5.3%5.76 USD9.01 USD0.33-17.91338.1KOn
17 Jul 20266.20 USD-0.6%5.74 USD9.00 USD0.55-25.05794.9KOn
10 Jul 20266.24 USD0.3%5.74 USD8.98 USD0.78-29.27738.6KOn
3 Jul 20266.22 USD-6.0%5.74 USD8.97 USD1.17-29.62885.1KOn
26 Jun 20266.62 USD3.3%5.75 USD8.95 USD1.52-26.212.6MOn
19 Jun 20266.41 USD-29.2%5.75 USD8.94 USD1.77-33.113.5MOn
12 Jun 20269.05 USD-9.2%5.75 USD8.92 USD1.81-5.104.6MOn
5 Jun 20269.97 USD27.4%5.66 USD8.89 USD1.665.358.0MOff
29 May 20267.83 USD40.3%5.57 USD8.86 USD1.60-22.012.9MOff
22 May 20265.58 USD8.5%5.58 USD8.83 USD1.50-43.91457.1KOff
15 May 20265.14 USD-3.2%5.68 USD8.82 USD1.57-48.85689.5KOff
8 May 20265.31 USD-1.7%5.79 USD8.82 USD1.49-48.572.0MOff
1 May 20265.40 USD6.9%5.91 USD8.81 USD1.06-46.051.1MOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.